Bell & Brown Wealth Advisors, LLC Rhythm Pharmaceuticals, Inc. Transaction History

Bell & Brown Wealth Advisors, LLC

  • $245 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$22.21 - $30.25 $923,936 - $1.26 Million
41,600 New
41,600 $1.21 Million
Q2 2022

Jul 22, 2022
SELL
$3.12 - $12.25 $146,640 - $575,750
-47,000 Reduced 40.03%
70,400 $293,000
Q1 2022

May 02, 2022
BUY
$6.13 - $12.24 $719,662 - $1.44 Million
117,400 New
117,400 $1.35 Million

Others Institutions Holding RYTM

# of Institutions
177
Shares Held
68.5M
Call Options Held
467K
Put Options Held
224K
View Full List

About RHYTHM PHARMACEUTICALS, INC.

RYTM Quotes by TradingView
  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $2.73B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Bell & Brown Wealth Advisors, LLC Portfolio

Follow Bell & Brown Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell & Brown Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bell & Brown Wealth Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email